高级检索
    叶升, 高惠冰. ViP研究评述: 延长癌中之王胰腺癌的生存期,任重而道远[J]. 循证医学, 2019, 19(5): 271-272. DOI: 10.12019/j.issn.1671-5144.2019.05.005
    引用本文: 叶升, 高惠冰. ViP研究评述: 延长癌中之王胰腺癌的生存期,任重而道远[J]. 循证医学, 2019, 19(5): 271-272. DOI: 10.12019/j.issn.1671-5144.2019.05.005
    shu
    YE Sheng, GAO Hui-bing. Review of The ViP Study: Pancreatic Cancer as The King of Cancer Would Like to Prolong Survival, Yet Has A Long Way to Go[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 271-272. DOI: 10.12019/j.issn.1671-5144.2019.05.005
    Citation: YE Sheng, GAO Hui-bing. Review of The ViP Study: Pancreatic Cancer as The King of Cancer Would Like to Prolong Survival, Yet Has A Long Way to Go[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 271-272. DOI: 10.12019/j.issn.1671-5144.2019.05.005
    shu

    ViP研究评述: 延长癌中之王胰腺癌的生存期,任重而道远

    Review of The ViP Study: Pancreatic Cancer as The King of Cancer Would Like to Prolong Survival, Yet Has A Long Way to Go

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回